Újabb adatok a gyulladásos izombetegségekrol

Translated title of the contribution: New data about inflammatory myopathies

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Idiopathic inflammatory myopathies are systemic autoimmune diseases with an immune-mediated inflammation of the striated muscles which lead to progressive muscle weakness. Their cause is still unknown, but recently the understanding of the molecular immunopathology has improved, which may as well offer therapeutic targets in the future. The aim of this review is to present currently available data on the most important factors and processes that are involved in the pathogenesis of these diseases. Although glucocorticoids remain the cornerstone of the treatment for the major forms of idiopathic inflammatory myopathies, there are other efficacious immunosuppressive agents with fewer side effects. The authors discuss classic treatment regimens as well as more recent therapeutic approaches.

Original languageHungarian
Pages (from-to)445-452
Number of pages8
JournalLege Artis Medicinae
Volume16
Issue number5
Publication statusPublished - May 2006

Fingerprint

Myositis
Striated Muscle
Muscle Weakness
Immunosuppressive Agents
Glucocorticoids
Autoimmune Diseases
Inflammation
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Újabb adatok a gyulladásos izombetegségekrol. / Dankó, K.; Ponyi, A.; Constantin, T.

In: Lege Artis Medicinae, Vol. 16, No. 5, 05.2006, p. 445-452.

Research output: Contribution to journalArticle

@article{caab6e4ff1924e44b0cd526675b691a9,
title = "{\'U}jabb adatok a gyullad{\'a}sos izombetegs{\'e}gekrol",
abstract = "Idiopathic inflammatory myopathies are systemic autoimmune diseases with an immune-mediated inflammation of the striated muscles which lead to progressive muscle weakness. Their cause is still unknown, but recently the understanding of the molecular immunopathology has improved, which may as well offer therapeutic targets in the future. The aim of this review is to present currently available data on the most important factors and processes that are involved in the pathogenesis of these diseases. Although glucocorticoids remain the cornerstone of the treatment for the major forms of idiopathic inflammatory myopathies, there are other efficacious immunosuppressive agents with fewer side effects. The authors discuss classic treatment regimens as well as more recent therapeutic approaches.",
keywords = "Dermatomyositis, Pathomechanism, Polymyositis, Treatment",
author = "K. Dank{\'o} and A. Ponyi and T. Constantin",
year = "2006",
month = "5",
language = "Hungarian",
volume = "16",
pages = "445--452",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "5",

}

TY - JOUR

T1 - Újabb adatok a gyulladásos izombetegségekrol

AU - Dankó, K.

AU - Ponyi, A.

AU - Constantin, T.

PY - 2006/5

Y1 - 2006/5

N2 - Idiopathic inflammatory myopathies are systemic autoimmune diseases with an immune-mediated inflammation of the striated muscles which lead to progressive muscle weakness. Their cause is still unknown, but recently the understanding of the molecular immunopathology has improved, which may as well offer therapeutic targets in the future. The aim of this review is to present currently available data on the most important factors and processes that are involved in the pathogenesis of these diseases. Although glucocorticoids remain the cornerstone of the treatment for the major forms of idiopathic inflammatory myopathies, there are other efficacious immunosuppressive agents with fewer side effects. The authors discuss classic treatment regimens as well as more recent therapeutic approaches.

AB - Idiopathic inflammatory myopathies are systemic autoimmune diseases with an immune-mediated inflammation of the striated muscles which lead to progressive muscle weakness. Their cause is still unknown, but recently the understanding of the molecular immunopathology has improved, which may as well offer therapeutic targets in the future. The aim of this review is to present currently available data on the most important factors and processes that are involved in the pathogenesis of these diseases. Although glucocorticoids remain the cornerstone of the treatment for the major forms of idiopathic inflammatory myopathies, there are other efficacious immunosuppressive agents with fewer side effects. The authors discuss classic treatment regimens as well as more recent therapeutic approaches.

KW - Dermatomyositis

KW - Pathomechanism

KW - Polymyositis

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=33744919800&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744919800&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33744919800

VL - 16

SP - 445

EP - 452

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 5

ER -